New study reveals flaws in AI tools used for SARS-CoV-2 antibody discovery

A discovery program for SARS-CoV-2-nABs potentially targeting its resistant strains.

Your Monday morning biotech news roundup

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hey there. Today, we

October 30, 2023

Building Mushroom Brands | Interview with Red Light Holland CEO, Todd Shapiro

September 20, 2023

Astellas withdraws lawsuit after evading Medicare drug price negotiations

WASHINGTON — Astellas was so sure that one of its drugs was going to be selected as part of Medicare’s new drug price negotiation program

September 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.